Identification and fermentation optimization of a marine-derived Streptomyces griseorubens with anti-tumor activity

Indian Journal of Marine Sciences

Volumn 38, Issue 1, 2009, Pages 14-21

  Ye, Liang ^a   Zhou, Qingfeng ^a   Liu, Chunhui ^a   Luo, Xuegang ^a   Na, Guangshui ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti tumor activity; ID50; Identification; Marine actinomycete; Optimization; Streptomyces griseorubens

Indexed keywords

BACTERIUM; CONCENTRATION (COMPOSITION); FERMENTATION; IDENTIFICATION METHOD; OPTIMIZATION; TUMOR; YEAST;

SOLANUM TUBEROSUM; STREPTOMYCES GRISEORUBENS;

EID: 69749126062     PISSN: 03795136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gontang E A, Fenical W & Jensen P R, Phylogenetic Diversity of Gram-Positive Bacteria Cultured From Marine Sediments, Appl Environ Microbiol, 73 (2007) 3272-3282.
2. Moore B S, Kalaitzis J A & Xiang L, Exploiting marine actinomycete biosynthetic pathways for drug discovery, Antonie Van Leeuwenhoek, 87 (2005) 49-57.
3. Newman D J & Cragg G M, Marine natural products and related compounds in clinical and advanced preclinical trials, J Nat Prod, 67 (2004) 1216-1238.
4. 1/7, Bioorg Khim, 32 (2006) 328-334.
5. Das S, Lyla P S & Khan S A, Marine microbial diversity and ecology: importance and future perspectives, Curr Sci India, 90 (2006) 1325-2335.
6. Fiedler H P, Bruntner C, Bull A T, Ward A C, Goodfellow M, Potterat O, Puder C & Mihm G, Marine actinomycetes as a source of novel secondary metabolites, Antonie van Leeuwenhoek, 87 (2005) 37-42.
7. Imada C, Enzyme inhibitors and other bioactive compounds from marine actinomycetes, Antonie Van Leeuwenhoek, 87 (2005) 59-63.
8. Surajit D, Lyla P S & Ajmal K S, Marine microbial diversity and ecology: importance and future perspectives, Curr Sci India, 90 (2006) 1325-1335.
9. Kwon H C, Kauffman C A, Jensen P R & Fenical W, Marinomycins A-D, anti-tumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "marinispora", J Am Chem Soc, 128(2006) 1622-1632.
10. Miller E D, Kauffman C A, Jensen P R & Fenical W, Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces, J Org Chem, 72 (2007) 323-330.
11. Jensen P R, Williams P G, Oh D C, Zeiqler L & Fenical W, Species-Specific Secondary Metabolite Production in Marine Actinomycetes of the Genus Salinispora, Appl Environ Microbiol, 73 (2007) 1146-1152.
12. Lam K S, Discovery of novel metabolites from marine actinomycetes, Curr Opin Microbiol, 9 (2006) 245-251.
13. Brandon E F, Sparidans R W, Meijerman I., Manzanares I, Beijnen J H & Schellens J H, In vitro characterization of the biotransformation of thiocoraline, a novel marine anti-cancer drug, Invest New Drug, 22 (2004) 241-251.
14. Chauhan D, Hideshima T & Anderson K C, A novel proteasome inhibitor NPI-0052 as an anticancer therapy, Brit J Cancer, 95 (2006) 961-965.
15. Reed K A, Manam R R & Mitchell S S, Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome, J Nat Prod, 70 (2007) 269-276.
16. Charan R D, Schlingmann G, Janso J, Bernan V, Feng X & Carter G T, Diazepinomicin, a new antimicrobial alkaloid from marine Micromonospora sp, J Nat Prod, 67 (2004) 1431-1433.
17. Fenical W, Chemical Studies of Marine Bacteria: Developing a New Resource, Chem Rew, 93 (1993) 1673-1683.
18. Jensen P R & Fenical W, Drug from the Sea, (Karger, Basel), 2000, pp. 6-28.
19. Jensen P R, Mincer T J, Williams P G & Fenical W, Marine actinomycete diversity and natural product discovery, Antonie Van Leeuwenhoek, 87 (2005) 43-48.
20. Mosmann T, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods, 65 (1983) 55-63.
21. Alley M C, Scudiero D A, Monks A, Hursey M L, Czerwinski M J, Fine D L, Abbott B J, Mayo J G, Shoemaker R H, & Boyd M R, Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay, Cancer Res, 48 (1988) 589-601.
22. Zheng Z H, Zeng W, Huang Y J, Yang Z Y, Li J, Cai H R & Su W J, Detection of anti-tumor and antimicrobial activities in marine organism associated actinomycetes isolated from the Taiwan Strait, China, FEMS Microbiol Lett, 188 (2000) 87-91.
23. Han T, Fernandez M, Chou T C & Agarwal R P, 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells, Biochem Biophys Res Commun, 316 (2004) 518-522.
24. Lechevalier H A, Bergey's Manual of Systematic Bacteriology, Vol 4 (Williams & Wilkin, Baltimore), 1989, pp. 2344-2347.
25. Yan X C, Taxonomy and Identification of Actinomycetes, (Chinese Sience Press, Beijing), 1992, pp. 583-584.
26. Staneck J L & Roberts G D, Simplified Approach to Identification of Aerobic Actinomycetes by Thin-Layer Chromatography, Appl Environ Microbiol, 28 (1974) 226-231.
27. Shirling E B & Gottlieb D, Methods for characterization of Streptomyces species, Int J Syst Bacteriol, 16 (1966) 313-340.
28. Waksman S A, The Actinomycetes, Classification, Identification and Description of Genera and Species, Vol 2 (Williams & Wilkin, Baltimore), 1961, pp. 328-334.
29. Chun J & Goodfellow M, A phylogenetic analysis of the genus Nocardia with 16S rRNA gene sequences, Int J Syst Bacteriol, 45 (1995) 240-245.
30. Barns S M, Pelletier D A & Lane D J, 16S ribosomal DNA amplification for phylogenetic study, J Bacteriol, 173 (1991) 697-703.
31. Edwards U, Rogall T, Blocker H, Emde M & Bottger E C, Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA, Nucleic Acids Res, 17 (1989) 7843-7853.
32. Chenna R, Sugawara H, Koike T, Lopez R, Gibson T J, Higgins D G & Thompson J D, Multiple sequence alignment with the Clustal series of programs, Nucleic Acids Res, 31 (2003) 3497-3500.
33. Kumar S, Tamura K, & Nei M, MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment, Brief Bioinform, 5 (2004) 150-163.
34. Kimura M, A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences, J Mol Evol, 16 (1980) 111-120.
35. Joo J H, Lim J M, Kim H O, Kim S W, Hwang H J, Choi J W & Yun J W, Optimization of submerged culture conditions for exopolysaccharide production in Sarcodon aspratus (Berk) S.lto TG-3, World J Microb Biot, 20 (2004) 767-773.
36. Preobrazhenskaya T P, Blinov N O & Ryabova I D, Problems of classification of actinomycetes-antagonists, (Government Publishing House of Medical Literature, Medgiz, Moscow) 1957, pp. 1-398.
37. Challis G L & Hopwood D A, Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Prod Nat Acad Sci U.S.A., 100 (2003) 14555-14561.